These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 35955774

  • 1. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL, Mitchell VA, Sokolaj EE, Winters BL, Vaughan CW.
    Int J Mol Sci; 2022 Aug 03; 23(15):. PubMed ID: 35955774
    [Abstract] [Full Text] [Related]

  • 2. Cannabis constituent synergy in a mouse neuropathic pain model.
    Casey SL, Atwal N, Vaughan CW.
    Pain; 2017 Dec 03; 158(12):2452-2460. PubMed ID: 28885457
    [Abstract] [Full Text] [Related]

  • 3. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
    Mitchell VA, Harley J, Casey SL, Vaughan AC, Winters BL, Vaughan CW.
    Neuropharmacology; 2021 May 15; 189():108529. PubMed ID: 33741405
    [Abstract] [Full Text] [Related]

  • 4. THC and gabapentin interactions in a mouse neuropathic pain model.
    Atwal N, Casey SL, Mitchell VA, Vaughan CW.
    Neuropharmacology; 2019 Jan 15; 144():115-121. PubMed ID: 30312630
    [Abstract] [Full Text] [Related]

  • 5. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.
    Eeswara A, Pacheco-Spiewak A, Jergova S, Sagen J.
    PLoS One; 2023 Jan 15; 18(3):e0282920. PubMed ID: 36913400
    [Abstract] [Full Text] [Related]

  • 6. Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.
    King KM, Myers AM, Soroka-Monzo AJ, Tuma RF, Tallarida RJ, Walker EA, Ward SJ.
    Br J Pharmacol; 2017 Sep 15; 174(17):2832-2841. PubMed ID: 28548225
    [Abstract] [Full Text] [Related]

  • 7. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
    Britch SC, Craft RM.
    J Pain; 2023 Jan 15; 24(1):98-111. PubMed ID: 36122809
    [Abstract] [Full Text] [Related]

  • 8. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L, Guindon J, Cornett BL, Makriyannis A, Mackie K, Hohmann AG.
    Biol Psychiatry; 2015 Mar 01; 77(5):475-87. PubMed ID: 24853387
    [Abstract] [Full Text] [Related]

  • 9. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
    Rodriguez CEB, Ouyang L, Kandasamy R.
    Behav Pharmacol; 2022 Apr 01; 33(2&3):130-157. PubMed ID: 33709984
    [Abstract] [Full Text] [Related]

  • 10. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.
    Nutt DJ, Phillips LD, Barnes MP, Brander B, Curran HV, Fayaz A, Finn DP, Horsted T, Moltke J, Sakal C, Sharon H, O'Sullivan SE, Williams T, Zorn G, Schlag AK.
    Cannabis Cannabinoid Res; 2022 Aug 01; 7(4):482-500. PubMed ID: 33998895
    [Abstract] [Full Text] [Related]

  • 11. A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
    Solowij N, Broyd S, Greenwood LM, van Hell H, Martelozzo D, Rueb K, Todd J, Liu Z, Galettis P, Martin J, Murray R, Jones A, Michie PT, Croft R.
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb 01; 269(1):17-35. PubMed ID: 30661105
    [Abstract] [Full Text] [Related]

  • 12. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.
    Carey LM, Maguire DR, France CP.
    Drug Alcohol Depend; 2023 Mar 01; 244():109787. PubMed ID: 36753805
    [Abstract] [Full Text] [Related]

  • 13. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.
    Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M.
    Neuropsychopharmacology; 2018 Jan 01; 43(1):142-154. PubMed ID: 28875990
    [Abstract] [Full Text] [Related]

  • 14. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA, Spindle TR, Surujunarain R, Weerts EM, Bansal S, Unadkat JD, Paine MF, Vandrey R.
    JAMA Netw Open; 2023 Feb 01; 6(2):e2254752. PubMed ID: 36780161
    [Abstract] [Full Text] [Related]

  • 15. Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain.
    Wall MB, Freeman TP, Hindocha C, Demetriou L, Ertl N, Freeman AM, Jones AP, Lawn W, Pope R, Mokrysz C, Solomons D, Statton B, Walker HR, Yamamori Y, Yang Z, Yim JL, Nutt DJ, Howes OD, Curran HV, Bloomfield MA.
    J Psychopharmacol; 2022 Jun 01; 36(6):732-744. PubMed ID: 35596578
    [Abstract] [Full Text] [Related]

  • 16. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
    Morris T, Cucinello-Ragland JA, Marks TJ, Prevost K, Glenn JF, Davenport GJ, Edwards S, Winsauer PJ.
    Pharmacol Biochem Behav; 2024 Feb 01; 235():173692. PubMed ID: 38128766
    [Abstract] [Full Text] [Related]

  • 17. Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain.
    Rock EM, Limebeer CL, Parker LA.
    Psychopharmacology (Berl); 2018 Nov 01; 235(11):3259-3271. PubMed ID: 30225659
    [Abstract] [Full Text] [Related]

  • 18. A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.
    Jones É, Vlachou S.
    Molecules; 2020 Oct 25; 25(21):. PubMed ID: 33113776
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, Martín de Llano JJ, Camps C, Galbis J, Carretero J, Carda C.
    PLoS One; 2020 Oct 25; 15(2):e0228909. PubMed ID: 32049991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.